We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Pharmacy (P), prescription-only (POM), and general sale list (GSL) medicines: apply to move your medicine to a different classification.
Letters from ESFA on the reclassification of the college sector, along with a new borrowing request form and a college interim regularity return
Guidance on how to reclassify your medicine and how to name medicines.
Expanding medicine reclassification could improve access to treatments, empower self-care, and reduce pressure on NHS services.
Guidance for the FE sector in England to help them meet ‘Managing Public Money’ requirements, and other obligations resulting from reclassification.
The UK Medicines Reclassification Platform for the reclassification of non-prescription medicines aims to increase stakeholder engagement in the reclassification process and to ensure the public receives maximum benefit from wider access to medicines when it is safe to do so.
The Advisory Council on the Misuse of Drugs (ACMD) has today (28 January 2026) published its updated harms assessment of ketamine.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).